KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Capital Expenditures (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Capital Expenditures for 9 consecutive years, with $62.0 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 31.91% to $62.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $276.0 million through Dec 2025, up 87.76% year-over-year, with the annual reading at $276.0 million for FY2025, 87.76% up from the prior year.
  • Capital Expenditures hit $62.0 million in Q4 2025 for Elanco Animal Health, down from $92.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $148.0 million in Q4 2021 to a low of -$1.0 million in Q3 2021.
  • Historically, Capital Expenditures has averaged $44.6 million across 5 years, with a median of $41.5 million in 2023.
  • Biggest five-year swings in Capital Expenditures: plummeted 85.11% in 2021 and later soared 3700.0% in 2022.
  • Year by year, Capital Expenditures stood at $148.0 million in 2021, then tumbled by 47.97% to $77.0 million in 2022, then plummeted by 46.75% to $41.0 million in 2023, then increased by 14.63% to $47.0 million in 2024, then soared by 31.91% to $62.0 million in 2025.
  • Business Quant data shows Capital Expenditures for ELAN at $62.0 million in Q4 2025, $92.0 million in Q3 2025, and $57.0 million in Q2 2025.